Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Kuang-Ming Liao, Jhi-Joung Wang & Chung-Han Ho. (2023) Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1057-1066.
Read now
Read now
Maaike Giezeman, Josefin Sundh, Åsa Athlin, Karin Lisspers, Björn Ställberg, Christer Janson, Scott Montgomery, Marta A Kisiel, Anna Nager, Hanna Sandelowsky & Mikael Hasselgren. (2023) Comorbid Heart Disease in Patients with COPD is Associated with Increased Hospitalization and Mortality – A 15-Year Follow-Up. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 11-21.
Read now
Read now
Gabriella Eliason, Christer Janson, Gunnar Johansson, Kjell Larsson, Anders Lindén, Claes-Göran Löfdahl, Thomas Sandström & Josefin Sundh. (2023) Comorbid conditions as predictors of mortality in severe COPD – an eight-year follow-up cohort study. European Clinical Respiratory Journal 10:1.
Read now
Read now
Robert A Wise, Peter MA Calverley, Kerstine Carter, Emmanuelle Clerisme-Beaty, Norbert Metzdorf & Antonio Anzueto. (2018) Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 605-616.
Read now
Read now
Alessandro Marcon, Mario Saugo & Ugo Fedeli. (2016) COPD-Related Mortality and Co-morbidities in Northeastern Italy, 2008-2012: A Multiple Causes of Death Analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease 13:1, pages 35-41.
Read now
Read now
Lorcan McGarvey, Dennis Niewoehner, Sheldon Magder, Paul Sachs, Kay Tetzlaff, Alan Hamilton, Lawrence Korducki, Ulrich Bothner, Claus Vogelmeier, Andrea Koch & Gary T. Ferguson. (2015) One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2–4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:5, pages 484-493.
Read now
Read now
Cristine E. Berry & Robert A. Wise. (2010) Mortality in COPD: Causes, Risk Factors, and Prevention. COPD: Journal of Chronic Obstructive Pulmonary Disease 7:5, pages 375-382.
Read now
Read now
Articles from other publishers (37)
Simone Scarlata, Sonia Zotti, Panaiotis Finamore, Christian R. Osadnik, Nicola Scichilone, Raffaele Antonelli Incalzi, Pedone Claudio & Matteo Cesari. (2023) Frailty in the chronic respiratory patient: association with mortality and clinical features in obstructive, restrictive, and mixed spirometric patterns. Aging Clinical and Experimental Research 35:11, pages 2573-2581.
Crossref
Crossref
Ugo Fedeli, Veronica Casotto, Claudio Barbiellini Amidei, Andrea Vianello & Gabriella Guarnieri. (2023) COPD-Related Mortality before and after Mass COVID-19 Vaccination in Northern Italy. Vaccines 11:8, pages 1392.
Crossref
Crossref
Lucia Cayuela, Jose Luis Lopez-Campos, Anna Michela Gaeta, Rocio Reinoso-Arija & Aurelio Cayuela. (2023) Chronic obstructive pulmonary disease mortality trends in Spain, 1980-2020. Epidemiology and Health.
Crossref
Crossref
Natalie Suder Egnot, Hannah Allen, Rebecca Hazan, Mark F. Vater, Hristina Denic-Roberts, Renee LeClaire & Gary M. Marsh. (2023) Systematic review of epidemiological studies evaluating the association between exposure to man-made vitreous fibers and non-malignant respiratory diseases. Regulatory Toxicology and Pharmacology 139, pages 105361.
Crossref
Crossref
Allie Morgan, Thomas Andrew, Sylvia M. A. Guerra, Valeria Luna, Louise Davies & Judy R. Rees. (2022) Provider reported challenges with completing death certificates: A focus group study demonstrating potential sources of error. PLOS ONE 17:5, pages e0268566.
Crossref
Crossref
Paolo Solidoro, Carlo Albera, Fulvia Ribolla, Michela Bellocchia, Luisa Brussino & Filippo Patrucco. (2022) Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?. Frontiers in Medicine 9.
Crossref
Crossref
D. Jovičić Burić, M. Erceg & N. Antoljak. (2022) Gender differences in specific trends of COPD mortality in Croatia. Public Health 202, pages 26-31.
Crossref
Crossref
Knut Stavem, Ane Johannessen, Rune Nielsen & Amund Gulsvik. (2021) Respiratory symptoms and respiratory deaths: A multi-cohort study with 45 years observation time. PLOS ONE 16:11, pages e0260416.
Crossref
Crossref
Alberto Fernández-García, Mónica Pérez-Ríos, Alberto Fernández-Villar, Gael Naveira, Cristina Candal-Pedreira, María Isolina Santiago-Pérez, Cristina Represas-Represas, Alberto Malvar-Pintos, Sara Cerdeira-Caramés & Alberto Ruano-Raviña. (2021) Four Decades of COPD Mortality Trends: Analysis of Trends and Multiple Causes of Death. Journal of Clinical Medicine 10:5, pages 1117.
Crossref
Crossref
Johanna Karlsson Sundbaum, Lowie E.G.W. Vanfleteren, Jon R. Konradsen, Fredrik Nyberg, Ann Ekberg-Jansson & Caroline Stridsman. (2021) Severe COVID-19 among patients with asthma and COPD: a report from the Swedish National Airway Register. Therapeutic Advances in Respiratory Disease 15, pages 175346662110497.
Crossref
Crossref
Sarah H. Cross, Joshua R. Lakin, Mallika Mendu, Ernest I. Mandel & Haider J. Warraich. (2021) Trends in Place of Death for Individuals With Deaths Attributed to Advanced Chronic or End-Stage Kidney Disease in the United States. Journal of Pain and Symptom Management 61:1, pages 112-120.e1.
Crossref
Crossref
Sarah H. Cross, E. Wesley Ely, Dio Kavalieratos, James A. Tulsky & Haider J. Warraich. (2020) Place of Death for Individuals With Chronic Lung Disease. Chest 158:2, pages 670-680.
Crossref
Crossref
Jacqueline M. Ferguson, Sadie Costello, Holly Elser, Andreas M. Neophytou, Sally Picciotto, Debra T. Silverman & Ellen A. Eisen. (2020) Chronic obstructive pulmonary disease mortality: The Diesel Exhaust in Miners Study (DEMS). Environmental Research 180, pages 108876.
Crossref
Crossref
Alicia V Gayle, Eleanor L Axson, Chloe I Bloom, Vidya Navaratnam & Jennifer K Quint. (2019) Changing causes of death for patients with chronic respiratory disease in England, 2005-2015. Thorax 74:5, pages 483-491.
Crossref
Crossref
Ulrich Mueller & Andrea Werdecker. 2019. Die ärztliche Leichenschau. Die ärztliche Leichenschau
255
270
.
Kjell Torén, Martin Andersson, Anna-Carin Olin, Paul D. Blanc & Bengt Järvholm. (2018) Airflow limitation classified with the fixed ratio or the lower limit of normal and cause-specific mortality - A prospective study. Respiratory Medicine 144, pages 36-41.
Crossref
Crossref
Josivan Gomes Lima, Lucia Helena C. Nobrega, Natalia Nobrega Lima, Marcel Catão Ferreira dos Santos, Pedro Henrique Dantas Silva, Maria de Fatima P. Baracho, Debora Nobrega Lima, Julliane Tamara Araújo de Melo Campos, Leonardo Capistrano Ferreira, Francisco Paulo Freire Neto, Carolina de O. Mendes-Aguiar & Selma Maria B. Jeronimo. (2018) Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy. PLOS ONE 13:6, pages e0199052.
Crossref
Crossref
Peter Hobson & Jolyon Meara. (2018) Mortality and quality of death certification in a cohort of patients with Parkinson’s disease and matched controls in North Wales, UK at 18 years: a community-based cohort study. BMJ Open 8:2, pages e018969.
Crossref
Crossref
Cécile Couchoud, Clémence Béchade, Abdelkader Bemrah, Jean-Christophe Delarozière & Guillaume Jean. (2017) Chronic respiratory disease: an unrecognized risk factor in dialysis. Nephrology Dialysis Transplantation 32:12, pages 2118-2125.
Crossref
Crossref
Joachim Cohen, Kim Beernaert, Lieve Van den Block, Lucas Morin, Katherine Hunt, Guido Miccinesi, Marylou Cardenas-Turanzas, Bregje Onwuteaka-Philipsen, Rod MacLeod, Miguel Ruiz-Ramos, Donna M Wilson, Martin Loucka, Agnes Csikos, Yong-Joo Rhee, Joan Teno, Winne Ko, Luc Deliens & Dirk Houttekier. (2017) Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data. npj Primary Care Respiratory Medicine 27:1.
Crossref
Crossref
Robert A. Wise, Peter R. Kowey, George Austen, Achim Mueller, Norbert Metzdorf, Andy Fowler & Lorcan P. McGarvey. (2017) Discordance in investigator-reported and adjudicated sudden death in TIOSPIR. ERJ Open Research 3:1, pages 00073-2016.
Crossref
Crossref
Emily Lauer, Pauline Heslop & Matthew Hoghton. 2015. Health Disparities and Intellectual Disabilities. Health Disparities and Intellectual Disabilities
195
245
.
Martin Loucka, Sheila A Payne & Sarah G Brearley. (2014) Place of death in the Czech Republic and Slovakia: a population based comparative study using death certificates data. BMC Palliative Care 13:1.
Crossref
Crossref
Cristina Represas Represas, Alberto Ruano Ravi?a & Alberto Fern?ndez Villar. (2014) Cambios en la tendencia sobre la mortalidad por enfermedad pulmonar obstructiva cr?nica: ?realidad o ficci?n?. Archivos de Bronconeumolog?a 50:8, pages 311-312.
Crossref
Crossref
Cristina Represas Represas, Alberto Ruano Raviña & Alberto Fernández Villar. (2014) Changes in Chronic Obstructive Pulmonary Disease Mortality Trends: Fact or Fiction?. Archivos de Bronconeumología (English Edition) 50:8, pages 311-312.
Crossref
Crossref
Michelle T Harrison, Philip Short, Peter A Williamson, Aran Singanayagam, James D Chalmers & Stuart Schembri. (2014) Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?. Thorax 69:7, pages 609-615.
Crossref
Crossref
Jason P. Lott & Cary P. Gross. (2014) Mortality from nonneoplastic skin disease in the United States. Journal of the American Academy of Dermatology 70:1, pages 47-54.e1.
Crossref
Crossref
Jose Luis L?pez-Campos, Miguel Ruiz-Ramos & Joan B Soriano. (2014) Mortality trends in chronic obstructive pulmonary disease in Europe, 1994?2010: a joinpoint regression analysis. The Lancet Respiratory Medicine 2:1, pages 54-62.
Crossref
Crossref
U Mueller & A Werdecker. 2014. Die ärztliche Leichenschau. Die ärztliche Leichenschau
227
238
.
Jose Luis López-CamposMiguel Ruiz-RamosCamila MendezJavier García-León. (2013) Characteristics of Subjects Who Died of Chronic Obstructive Pulmonary Disease in Andalusia in 2010 and 2011. Journal of Palliative Medicine 16:12, pages 1610-1613.
Crossref
Crossref
Teun van der Bom, Berto J. Bouma, Folkert J. Meijboom, Aeilko H. Zwinderman & Barbara J.M. Mulder. (2012) The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation. American Heart Journal 164:4, pages 568-575.
Crossref
Crossref
Josefin Sundh, Christer Janson, Karin Lisspers, Björn Ställberg & Scott Montgomery. (2012) The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD. Primary Care Respiratory Journal 21:3, pages 295-301.
Crossref
Crossref
Steven L. Due, David A. Wattchow, James L. Sweeney, Lesley Milliken & Colin G. Luke. (2012) Colorectal cancer surgery 2000–2008: evaluation of a prospective database. ANZ Journal of Surgery 82:6, pages 412-419.
Crossref
Crossref
Lorcan P. McGarvey, Sheldon Magder, Deborah Burkhart, Steven Kesten, Dacheng Liu, Raymond C. Manuel & Denis E. Niewoehner. (2012) Cause-specific mortality adjudication in the UPLIFT? COPD trial: Findings and recommendations. Respiratory Medicine 106:4, pages 515-521.
Crossref
Crossref
Bart Van Rompaye, Shabbar Jaffar & Els Goetghebeur. (2012) Estimation With Cox Models. Epidemiology 23:2, pages 194-202.
Crossref
Crossref
Richard F.W. Barnes, Maria Luisa Moore, Richard S. Garfein, Stephanie Brodine, Steffanie A. Strathdee & Timothy C. Rodwell. (2011) Trends in Mortality of Tuberculosis Patients in the United States: The Long-Term Perspective. Annals of Epidemiology 21:10, pages 791-795.
Crossref
Crossref
David W. Brown & Roy A. Pleasants. (2011) Mortality from Chronic Obstructive Pulmonary Disease Among Adults Aged 25 Years or Older in North Carolina. Southern Medical Journal 104:1, pages 20-23.
Crossref
Crossref